Is a controlled trial of long-term oral anticoagulants in patients with stroke and non-rheumatic atrial fibrillation worthwhile?
A controlled randomised trial large enough to assess the value of anticoagulating stroke patients in atrial fibrillation would be difficult to conduct in the UK and the results would be applicable to only a small proportion of stroke patients. It would be more worthwhile to organise a trial that als...
Những tác giả chính: | Sandercock, P, Warlow, C, Bamford, J, Peto, R, Starkey, I |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
1986
|
Những quyển sách tương tự
-
A new era of anticoagulant therapy in the prevention of stroke in non-rheumatic atrial fibrillation
Bằng: Andrei Viktorovich Fonyakin, et al.
Được phát hành: (2012-09-01) -
Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
Bằng: Paula Tiili, et al.
Được phát hành: (2021-01-01) -
Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation
Bằng: Tommaso Sacquegna, et al.
Được phát hành: (2015-12-01) -
Prevalence of oral anticoagulation in atrial fibrillation
Bằng: Eduardo Bartholomay, et al.
Được phát hành: (2014-09-01) -
Oral anticoagulant decreases stroke recurrence in patients with atrial fibrillation detected after stroke
Bằng: Jin-Yi Hsu, et al.
Được phát hành: (2022-07-01)